| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-07 16:35 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Elliott, Christine Janice
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
7,670 | |
| Filed 2025-10-07 16:33 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Roy, Christian
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$37,402
+6,978 vol $5.36 each |
95,710 | |
| Filed 2025-10-07 16:30 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
112,438 | |
| Filed 2025-10-07 16:29 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
||
| Filed 2025-10-07 16:27 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$40,886
+7,628 vol $5.36 each |
119,466 | |
| Filed 2025-10-07 16:23 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
||
| Filed 2025-10-07 16:20 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$57,410
+10,711 vol $5.36 each |
217,234 | |
| Filed 2025-10-07 16:16 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$23,053
+4,301 vol $5.36 each |
127,692 | |
| Filed 2025-09-30 16:36 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,500 vol |
0 | |
| Filed 2025-09-30 16:36 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,755
+1,000 vol $5.75 each |
1,500 | |
| Filed 2025-09-30 16:35 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,850
+500 vol $5.70 each |
500 | |
| Filed 2025-09-30 16:35 Tx date 2025-09-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100 vol |
0 | |
| Filed 2025-09-30 16:34 Tx date 2025-09-29 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$550.00
+100 vol $5.50 each |
100 | |
| Filed 2025-09-30 16:34 Tx date 2025-09-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,300 vol |
0 | |
| Filed 2025-09-30 16:33 Tx date 2025-09-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,172
+2,100 vol $5.32 each |
5,300 | |
| Filed 2025-09-30 16:33 Tx date 2025-09-26 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,062
+3,200 vol $5.33 each |
3,200 | |
| Filed 2025-09-30 16:32 Tx date 2025-09-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,600 vol |
0 | |
| Filed 2025-09-30 16:31 Tx date 2025-09-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,492
+1,200 vol $5.41 each |
4,600 | |
| Filed 2025-09-30 16:31 Tx date 2025-09-25 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,572
+3,400 vol $5.46 each |
3,400 | |
| Filed 2025-09-30 16:30 Tx date 2025-09-24 |
$HLS
HLS Therapeutics Inc. |
HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500 vol |
0 |